Practice Management News

WASHINGTON — Some infants with in utero or early life exposure to SARS-CoV-2 had borderline to low developmental scores, a study found, and this was most common among babies born to mothers with symptomatic COVID-19.

From Oct. 22 to 26, ASRM will host its Scientific Congress & Expo in a fully in-person format for the first time in 3 years.

The FDA Obstetrics, Reproductive and Urologic Drugs Advisory Committee voted 14-1 to remove a drug indicated for preventing preterm birth from the market due to lack of effectiveness.

Arrivo BioVentures, a biopharmaceutical company, has announced preliminary results from a randomized, placebo-controlled phase 2 clinical trial of SP-624, a first-in-class, sirtuin 6 activator for the treatment of major depressive disorder.

A telemedicine program at Penn Medicine in Philadelphia halved patients’ time from initial visit for fertility care to receipt of treatment, data published in NEJM Catalyst Innovations in Care Delivery showed.

Potentially perimenopausal women who took relugolix combination therapy for uterine fibroids and heavy menstrual bleeding experienced significant reductions in menstrual bleeding and fibroid-related pain vs. those who took placebo.

Orthopedic surgeons, like any health care service provider, desire appropriate compensation for the work performed. After years of specialized training and education, we offer a unique benefit to health care systems.

Women who took a probiotic supplement for bothersome vaginal odor and symptoms such as irritation and painful urination reported substantial improvements within 2 weeks, according to study findings presented at the NAMS Annual Meeting.

Like their patients, physicians often become more concerned about long-term care coverage as they age.

Premenopausal and perimenopausal women with a history of migraines were more likely to experience poor sleep vs. those who did not have a history of migraines, according to a cross-sectional study presented at the NAMS Annual Meeting.